Page last updated: 2024-09-02
exp3174 and adenine
exp3174 has been researched along with adenine in 1 studies
Compound Research Comparison
| Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (adenine) | Trials (adenine) | Recent Studies (post-2010) (adenine) |
|---|---|---|---|---|---|
| 236 | 29 | 43 | 21,903 | 1,153 | 7,682 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| de Leeuw, PW; Kroon, AA; Spiering, W | 1 |
Other Studies
1 other study(ies) available for exp3174 and adenine
| Article | Year |
|---|---|
A116C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
Topics: Adenine; Alleles; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Cytosine; Heart Rate; Humans; Hypertension, Portal; Imidazoles; Liver Cirrhosis; Losartan; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Tetrazoles | 2005 |